The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
A US Supreme Court fight over how branded drugs’ makers must plead induced infringement in “skinny-label” patent suits could ...
The Supreme Court’s decision to review Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc. places renewed attention on a ...
(MENAFN- EIN Presswire) EINPresswire/ -- What Is The Expected Cagr For The Pharmaceutical Label Market Through 2025? In recent times, there has been a robust growth in the size of the pharmaceutical ...
By Blake Brittain WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving ...
DUBLIN, Dec. 10, 2019 /PRNewswire/ -- The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ...
DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's ...
Par Pharmaceutical last week asked a federal court to tell the FDA to back off and allow the company to detail docs about using its Megace ES to treat AIDS-related wasting. The appetite-stimulating ...
Pharmaceutical manufacturer AstraZeneca, based in Wilmington, Del., has agreed to pay $520 million to settle allegations that it had illegally marketed its antipsychotic drug Seroquel, according to an ...
Dublin, Dec. 10, 2019 (GLOBE NEWSWIRE) -- The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results